Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
Pastran
Z
Z
Comité de Pathologie thoracique, Institut Gustave-Roussy, Villejuif, France.
le Chevalier
T
T
Baldeyrou
P
P
Spielmann
M
M
Arriagada
R
R
Droz
J P
JP
Rouesse
J
J
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D015080:Mesna / Q000627:therapeutic use; D008875:Middle Aged
D015080:Mesna; D007069:Ifosfamide